2013
DOI: 10.1016/j.neuropharm.2012.09.008
|View full text |Cite
|
Sign up to set email alerts
|

Metabotropic glutamate 2/3 receptor antagonists improve behavioral and prefrontal dopaminergic alterations in the chronic corticosterone-induced depression model in mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
46
1

Year Published

2013
2013
2021
2021

Publication Types

Select...
9
1

Relationship

3
7

Authors

Journals

citations
Cited by 84 publications
(50 citation statements)
references
References 64 publications
3
46
1
Order By: Relevance
“…This is believed to release energy stores to help the animal cope with the stressful stimulus and, in turn, this surplus energy is used to display the behavioral responses [33]. Nevertheless, persistent secretion of corticosterone during chronic stress induces further energy loss and structural changes in several regions of the brain, which are accompanied by impairment of some brain functions, such as learning and memory [1].…”
Section: Discussionmentioning
confidence: 99%
“…This is believed to release energy stores to help the animal cope with the stressful stimulus and, in turn, this surplus energy is used to display the behavioral responses [33]. Nevertheless, persistent secretion of corticosterone during chronic stress induces further energy loss and structural changes in several regions of the brain, which are accompanied by impairment of some brain functions, such as learning and memory [1].…”
Section: Discussionmentioning
confidence: 99%
“…The FST was performed by a previously reported method, with some modification (Ago et al, 2013). Although immobility in the FST is a controversial measure of depressive-like behavior, it is a useful screen for compounds that are effective for the treatment of depression.…”
Section: Forced Swimming Testmentioning
confidence: 99%
“…Currently, it has been confi rmed that mGluR2/3 antagonists have antidepressant effects [65] that have many features in common with those of ketamine. This is because mGluR2/3 regulates glutamate release by negative feedback; hence, glutamate release in the synaptic cleft is largely enhanced after blocking mGluR2/3, and the increased glutamate further activates AMPARs and facilitates the activation of the downstream PI3K-AKT-mTOR pathway to exert antidepressant effects.…”
Section: The Abnormal Glutamate Receptors Hypothesis and Related New mentioning
confidence: 99%